FBT News and Press, First Trust Amex Biotech Index Fund From 08/13/21

In any market’s upswing, there are always going to be people who make the case that “it’s different this time”, and historically, most of the time, that argument doesn’t hold up. I have never seen so many interesting and novel therapeutic opportuniti...

The healthcare sector ranks fifth in Q3'21. Based on an aggregation of ratings of the 351 stocks in the healthcare sector. PPH is our top-rated healthcare sector ETF and FSHCX is our top-rated healthcare sector mutual fund. For further details see: Best And Worst Q3 2021...

From a consumer perspective, the consumer is actually now demanding a focus on environmental, social, governance factors. If public expectations for inflation do rise, that is going to be a change from years past. There’s going to be an opportunity to make medical progress ...

Biotechs are ready to march forcefully higher after a lengthy consolidation. Approval of Biogen's Alzheimer's treatment creates a bonanza for neurodegenerative-focused companies and the overall biotech sector. The lower bar set for approval poses risk for Biogen in the out years. ...

The Healthcare sector ranks second in Q2'21. Based on an aggregation of ratings of the 351 stocks in the Healthcare sector. PPH is our top-rated Healthcare sector ETF and PGHAX is our top-rated Healthcare sector mutual fund. For further details see: Best And Worst Q2 202...

Opportunities and risks in the healthcare sector. The next big areas of innovation in healthcare. Extreme winners and losers in the healthcare sector. For further details see: Building A Healthy Portfolio: Spotlight On Healthcare

In January 2020, only 0.24% of total medical claims in the U.S. were telemedicine-related. One year later, they totaled 7%. It took 15 years for e-commerce penetration to rise from less than 1% to over 7%. The pandemic helped telemedicine do it in one. Population-wide immunity to ...

If you were investing heavily in tech/growth stocks over the past 11 years, we wish to congratulate you. We're not here to say that the next 11 years won't be the same, rather to suggest that you should treat your portfolio the same way you treat your body. If you've vaccinated yo...

This has been a long, long boom in the amount of money that's flowed into this sector, and I don't think I've ever seen anything like it in my own career. This has been VC money going into early-stage startups, it's been IPOs, it's been follow-on financing of already public companies....

Since U.S. Treasury bonds have fallen more than -20% in value, it looks like we might've seen a short-term bottom and an opportunity to profit in the bond market. Which sectors are performing well in the intermediate term, as well as those that are taking a breather in the short term....